What are the non‑ischemic causes of dilated cardiomyopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Non-Ischemic Causes of Dilated Cardiomyopathy

Non-ischemic dilated cardiomyopathy results from genetic mutations (30-50% of cases), viral myocarditis, cardiotoxic substances (alcohol, chemotherapy, recreational drugs), endocrine/metabolic disorders, peripartum state, tachyarrhythmias, autoimmune diseases, nutritional deficiencies, and infiltrative diseases. 1

Genetic and Familial Causes

  • Genetic mutations account for 30-50% of all DCM cases, with 30-40% attributable to identifiable pathogenic variants in specific protein genes affecting cytoskeletal and sarcomeric proteins. 1
  • A 3-generation family history should be obtained when evaluating DCM, as familial patterns are common. 2
  • Several inherited muscular dystrophies produce DCM, presenting with heart failure, arrhythmias, or sudden death. 3

Infectious and Inflammatory Causes

  • Viral myocarditis represents a well-established pathway from acute inflammation to chronic DCM, with cell-mediated autoimmune mechanisms triggered by viral infection driving progression. 1
  • Viral myocarditis accounts for up to 75% of patients presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA). 2
  • Bacterial, fungal, or tuberculosis infections can cause cardiomyopathy. 2
  • Chagas disease (Trypanosoma cruzi) is endemic in Central and South America and leads to cardiomyopathy. 2
  • HIV-associated cardiomyopathy occurs in approximately 8% of asymptomatic HIV-positive individuals. 2

Cardiotoxic Substances

Alcohol

  • Alcohol is a common and reversible cause of DCM when consumption is stopped early, particularly affecting men aged 30-55 years with heavy drinking history and probable genetic susceptibility. 1, 2

Chemotherapeutic Agents

  • Anthracyclines and other cancer treatments cause direct myocyte injury leading to DCM. 1
  • Tyrosine kinase inhibitors, trastuzumab, and interferons can also cause cardiomyopathy. 2

Recreational Drugs

  • Cocaine and methamphetamine lead to cardiomyopathy through direct cardiotoxic effects. 2

Endocrine and Metabolic Disorders

  • Diabetes mellitus contributes to secondary cardiomyopathy through metabolic derangements. 1
  • Thyroid disorders (both hypo- and hyperthyroidism) affect cardiac contractility and can cause or contribute to heart failure. 1, 2
  • Acromegaly and pheochromocytoma are associated with cardiomyopathy. 2
  • Nutritional deficiencies (thiamine, carnitine, selenium) cause reversible DCM when severe. 1
  • Hemochromatosis and other metabolic storage diseases lead to cardiomyopathy through iron deposition and should be screened with fasting transferrin saturation. 2

Pregnancy-Related

  • Peripartum cardiomyopathy presents during the last month of pregnancy or within 5 months postpartum, with an incidence of 1 in 2,500-4,000 births in the United States. 1, 3
  • Risk factors include multiparity, advanced maternal age (>30 years), obesity, nonwhite background, poor socioeconomic status, prolonged tocolytic therapy, hypertension, preeclampsia, and cocaine use. 1, 3
  • Endomyocardial biopsy may be needed to exclude myocarditis in these patients. 3

Arrhythmia-Induced

  • Tachycardia-induced cardiomyopathy results from chronic supraventricular or ventricular arrhythmias with rapid rates, causing reversible systolic dysfunction. 1

Autoimmune and Inflammatory Disorders

  • Systemic lupus erythematosus, dermatomyositis, rheumatoid arthritis, scleroderma, and polyarteritis nodosa all associate with DCM through immune-mediated myocardial damage. 1
  • Sarcoidosis can cause cardiomyopathy, though characteristic changes are often missed on histological evaluation. 2

Infiltrative Diseases

  • Amyloidosis, hemochromatosis, and sarcoidosis cause secondary cardiomyopathy as part of multiorgan systemic disease. 1

Stress-Related

  • Stress-induced (Takotsubo) cardiomyopathy presents with acute, usually reversible LV dysfunction triggered by emotional or physical stress, mediated by catecholamine excess. 1, 3
  • It presents similarly to acute myocardial infarction with chest pain, ST-segment elevation on ECG, and elevated cardiac enzymes. 3
  • Diagnosis is made based on Mayo Clinic or InterTAK diagnostic criteria. 3
  • Important caveat: Incidental coronary artery disease is found in 10% of patients with stress-induced cardiomyopathy, complicating diagnosis. 3, 2

Hypertensive Heart Disease

  • Long-standing uncontrolled hypertension leads to "burned-out" dilated cardiomyopathy after initial concentric hypertrophy, with progressive chamber dilation and declining ejection fraction. 1

Cirrhosis-Related

  • Cardiomyopathy can be seen in cirrhotic patients, independent of alcohol exposure. 3

Unclassified Entities

  • LV non-compaction is characterized by prominent trabeculations due to persistent embryonic sinusoids, leading to LV failure, thromboembolism, and arrhythmias. 3, 2

Critical Diagnostic Pitfall

Approximately 50% of patients with heart failure and reduced ejection fraction have normal or near-normal coronary arteries on angiography, making systematic evaluation for non-ischemic causes essential. 2 Endomyocardial biopsy may be necessary in certain cases, particularly to exclude myocarditis, though it is not indicated in routine evaluation. 2

References

Guideline

Causes of Dilated Cardiomyopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Non-Ischemic Cardiomyopathy Causes and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What does a cardiac MRI showing no scar (fibrosis or infarction) on cardiovascular magnetic resonance, normal native T1, and markedly elevated extracellular volume (ECV) indicating diffuse fibrosis, consistent with non‑ischemic dilated cardiomyopathy without evidence of acute inflammatory infiltrative cardiomyopathy mean?
What are the causes of dilated cardiomyopathy?
What is the difference between ischemic and nonischemic cardiomyopathy in terms of causes, treatment, and management?
What is the initial workup for a young patient with suspected Non-Ischemic Cardiomyopathy (NICM)?
What lab tests are recommended for a patient with suspected non-ischemic cardiomyopathy?
How do I document a telephone encounter reviewing laboratory results with a patient?
How does albuterol (short‑acting β2‑adrenergic agonist) work in the body, what are its indications, key nursing assessments before and after administration, side effects, nursing considerations, and which subjective and objective findings indicate that the drug is effective?
What is an incarcerated uterus?
How do I use low‑dose and high‑dose dexamethasone suppression tests to evaluate a pituitary microadenoma for Cushing’s disease and decide on treatment?
Is there evidence that low ferritin is associated with disease activity in systemic lupus erythematosus?
How does the Pfizer‑BioNTech COVID‑19 vaccine (Comirnaty, generic BNT162b2) work in the body, what are the key pre‑vaccination assessments, common and serious adverse effects, nursing considerations, and the rationale for its use in a client?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.